Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these https://berthagsia716884.timeblog.net/71896889/retatrutide-a-promising-new-treatment-for-obesity